Qualitative Feedback on Food
and Drug Administration Service Delivery
Extension without change of a currently approved collection
No
Regular
11/28/2023
Requested
Previously Approved
36 Months From Approved
12/31/2023
15,752
15,752
8,491
8,491
0
0
The information collected from our
customers and stakeholders will help ensure that users have an
effective, efficient, and satisfying experience with FDA's
programs. This feedback will provide insights into customer or
stakeholder perceptions, experiences and expectations, provide an
early warning of issues with service, or focus attention on areas
where communication, training or changes in operations might
improve delivery of products or services. These collections will
allow for ongoing, collaborative and actionable communications
between FDA and its customers and stakeholders. It will also allow
feedback to contribute directly to the improvement of program
management.
EO: EO
12862 Name/Subject of EO: Setting Customer Service Standards
Based on a review of the
information collection since our last request for OMB approval, we
increased the number of respondents for focus groups, customer
comment cards/forms, customer satisfaction surveys, and usability
studies. This adjustment results in an overall burden increase of
6,234 hours.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.